Olon USA is proud to announce its participation in this year’s AAPS PharmSci 360, taking place November 9–12, 2025, at the Henry B. González Convention Center in San Antonio, Texas. This premier conference brings together the life sciences community—from CDMOs and pharmaceutical companies to biopharmaceutical innovators—to explore the technologies, trends, and partnerships driving drug development forward.
For the first time, Olon USA will be showcasing its capabilities as part of the Olon Group, a global leader in active pharmaceutical ingredient (API) development and manufacturing. This event marks a key opportunity for attendees to see how Olon’s U.S.-based operations integrate seamlessly with its worldwide network, offering a strategic balance of local execution and global scale.
A Year Defined by Growth and Global Alignment
2025 has been a milestone year for Olon USA. Following successful FDA outcomes on programs including Aceclidine and Rotigotine, and a recent General Surveillance Inspection with no resulting observations, the team has continued to strengthen its operations, quality systems, and expand capacity at its U.S. facility. These achievements have positioned Olon USA as a cornerstone of the Olon Group’s global network, combining domestic manufacturing excellence with international reach.
At PharmSci 360, Olon will highlight ongoing investment in high-potency API manufacturing, part of a broader strategic initiative to advance complex and emerging therapeutic modalities. Visitors will also have the opportunity to discuss how Olon USA is expanding its site with new capacity and equipment to support larger-scale commercial manufacturing—a critical capability as the market demands more flexible and reliable domestic production.
Addressing Global Challenges with Local Solutions
API development and manufacturing programs today face unprecedented challenges—tariff uncertainties, supply chain disruption, and evolving regulatory expectations. These issues can introduce delays and risk for projects reliant on global sourcing.
Olon USA helps customers overcome these challenges through its integrated procurement and production network spanning the United States, Europe, India, and China. This infrastructure provides clients with both stability and agility, ensuring secure material flow, regulatory compliance, and cost control even amid fluctuating global conditions.
Whether supporting early-stage development or commercial manufacturing, Olon USA’s model allows clients to pursue domestic programs, leverage global scale, or combine both strategies—all while maintaining consistent quality and oversight under one unified group.
Collaboration Without Barriers
Olon USA operates with a simple but powerful principle: scientific collaboration without unnecessary barriers. At every stage of a project, clients work directly with Olon’s development scientists and technical experts, ensuring clear communication, rapid feedback, and informed decision-making. This transparent, hands-on approach helps maintain program timelines and minimizes the risk of misalignment that can occur in more layered or fragmented outsourcing models.
At AAPS, visitors can meet these experts in person—including CEO Robert Poe and Olon USA technical specialists—to learn how Olon’s approach to partnership fosters trust, efficiency, and shared success.
Expanding Capacity and Partnership Models
Olon USA is taking bold steps to meet the growing demand for domestic API manufacturing. In addition to its physical expansion, the company is exploring collaborative partnership models that allow customers to establish operations within Olon’s U.S. campus, supported by Olon’s infrastructure and experienced staff. This unique offering provides a hybrid model for clients seeking greater control and flexibility within a GMP-compliant environment.
Meet Us in San Antonio
Olon USA invites all AAPS PharmSci 360 attendees to visit the Olon booth to explore new commercial manufacturing partnership opportunities, discuss ongoing R&D investments and development programs, and discover how Olon is redefining what it means to be a globally integrated CDMO.
Booth number: 3128
Dates: October 20–23, 2025
Location: Henry B. González Convention Center, San Antonio, TX
Click here to Schedule a Meeting with Us at the Conference
About Olon USA
Olon USA, part of the global Olon Group, provides integrated development and manufacturing services for active pharmaceutical ingredients (APIs). With state-of-the-art facilities in the United States and Europe, Olon combines scientific expertise, regulatory reliability, and a people-focused culture dedicated to quality, sustainability, and innovation.